As we leave behind a volatile 22 year, many investors will expect a quieter trading environment in the new year. Will the ASX stock market gain new momentum? For their thoughts, we asked our Foolish collaborators to compile a list of ASX shares that they believe could generate wealth in the coming years. Here is what the team came up with.
9 best ASX stocks for July 2022 (smallest to largest)
(Market capitalizations as of June 30, 2022)
Why our silly writers love these ASX actions
Airtasker Ltd
What it does: Airtasker has an online local service platform that allows people who need a completed task to connect with people who want the job. Examples of task categories include furniture assembly, removals, website design, personnel services, and accounting.
By Tristan Harrison: The volatility of Airasker stock prices has dropped it by more than 60% in 2022. I think this makes the company an attractive investment opportunity if we consider its growth and continuous potential.
In the third quarter of fiscal year 22, Airtasker saw revenue increase 21.2% to $ 8.6 million, while generating $ 1 million in positive operating cash flow.
It is growing rapidly internationally, opening up great potential markets. Gross third-quarter market volume in the UK rose 138% year-on-year, while growth in published jobs in the US rose 90% quarter-on-quarter.
With a gross profit margin of over 90%, I think this business can become very profitable as it achieves scale profits and does not need to invest too much to grow.
Motley Fool collaborator Tristan Harrison does not own shares in Airasker Ltd.
Kogan.com Ltd
What it does: Kogan is an online retailer with operations in Australia and New Zealand, including brands such as Dick Smith, Matt Blatt and Mighty Ape. The company has grown to become a one-stop shop for the online consumer, offering electricity plans, mobile plans, consumer goods, and more.
Mitchell Lawler: Anyone who has had Kogan shares for the past 12 months knows the pain; i am one of them. It has been a trip to a maximum of $ 25 each and back down to the current level of less than $ 3.
As with much of the market, the exuberance of the advanced “decades of online adoption” has faded and fears of an impending recession have pushed investors away from the discretionary consumer sector.
However, since 2018, Kogan has come a long way. Now, with more than 4 million active customers, online branding has become a staple among shoppers. With a multiple price-sale of 0.4 times, the sale could be exaggerated.
Mitchell Lawler, a partner at Motley Fool, owns shares in Kogan.com Ltd.
Adairs Ltd
What it does: Adairs is a home furniture retailer with over 170 stores in Australia and New Zealand.
By Brooke Cooper: The price of Adirs shares has struggled until 2022 so far, falling almost 50% so far to trading around $ 2.00.
Although the company suffered in the midst of COVID-19 outbreaks earlier this year, its payment loyalty program continued to grow. Linen Lovers was approaching one million members at the end of the first half, having risen 10% from the previous 12 months.
And the future of the retailer’s stock looks bright. My Fool colleague James reported that Morgans hit the stock with a target price of $ 3.50 in early June.
In addition, following the recent turmoil, Adirs shares offer an impressive dividend yield of around 9%.
Brooke Cooper, a collaborator of Motley Fool, does not own shares in Adirs Ltd.
BUBS Australia Ltd
What it does: Founded in 2006, Bubs produces and sells infant formula, organic baby foods and cereals in Australia and overseas markets.
By Aaron Teboneras: Bubs stock prices have continued to challenge the recent fall in the S & P / ASX 200 Index (ASX: XJO). By context, the company’s shares rose nearly 25% last month, while the ASX 200 benchmark index fell about 6%.
The current shortage of infant formula supply in the United States offers Bubs a unique opportunity to increase revenue. Bubs recently signed an agreement with the U.S. government to deliver at least 1.25 million cans of infant formula.
In addition, the company has been busy expanding its footprint in the country through new supply agreements with large distributors.
In light of this, Citi runner believes Bubs is about to grow significantly over the next year.
According to ANZ Share Investing, the broker increased its target price by 29% to 76 cents for Bubs shares. That implies an increase of approximately 24% based on today’s closing price of 61 cents.
Aaron Teboneras, a collaborator of Motley Fool, has no shares in BUBS Australia Ltd.
Rural Funds Group
What it does: Rural Funds is an agricultural real estate investment fund (REIT) that has a portfolio of farmland assets.
By Sebastian Bowen: There aren’t too many shares in the ASX that give an investor pure exposure to farmland and agricultural assets. But this is exactly what Rural Funds do. This REIT owns almond orchards, macadamia orchards, vineyards, as well as livestock and farmland. Rural Funds has a policy of increasing its dividend distributions by approximately 4% annually.
This Rural Fund has managed to do so very consistently in recent years, growing its annual payments from 9.3 cents per share in 2016 to 11.5 cents per share last year. With a dividend yield of more than 4.5% above recent prices, the Rural Funds Group could be a great place to look for an action that diversifies the portfolio and pays dividends this July.
Motley Fool contributor Sebastian Bowen has no shares in Rural Funds Group.
Deterra Royalties Ltd
What it does: Deterra is a mining stake with a difference. It does not perform any physical or similar mining. Instead, Deterra manages and grows its gift asset portfolio and distributes cash flow to shareholders through dividends.
By Zach Bristow: A dividend game for investors, Deterra works as a gift business model that oversees a portfolio of mining and commodity rights. His model claims to have lower risk and higher margin exposure in the resource sector.
Deterra’s strategy is to pay 100% of its net profit after tax (NPAT) to shareholders through dividends.
In fiscal year 21, it printed $ 94 million from NPAT and has a final dividend per share (DPS) of 23 cents. He confirmed $ 59 million in gift receipts last quarter.
According to Bloomberg data, the stock is valued uniformly with five brokers each saying it is a buy or hold at this time. From this list, the consensus target price is $ 4.70 per share.
Motley Fool collaborator Zach Bristow does not own shares in Deterra Royalties Ltd.
NIB Holdings Ltd.
What it does: NIB Holdings is a leading Australian insurance company and the first private health fund to be listed on the ASX in 2007.
By Bernd Struben: NIB currently offers more than 1.6 million aussies and kiwis with health and travel insurance. And its market share continues to grow slowly, going from 9.0% of the Australian-based health insurance market in 2019 to 9.3% in 2022.
The insurance industry is also one of the few that can thrive in higher interest rate environments. Insurers need to have plenty of safe debt to cover their policies, and as bond yields increase, so does their passive income.
NIB shares have risen 16% over the past 12 months. The company is also a reliable dividend payer, currently paying a subsequent dividend yield of 3.4%, fully franchised.
Bernd Struben, a collaborator of Motley Fool, has no shares in NIB Holdings.
ResMed Inc.
What it does: ResMed is a provider of medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders such as sleep apnea and chronic obstructive pulmonary disease (COPD).
By James Mickleboro: ResMed had a positive month in June and materially outperformed the ASX 200 index. Still, I don’t think it’s too late to make an investment, especially considering that its shares continue to fall significantly so far despite last month’s earnings.
This is because I believe the company is well placed to continue its strong sales and earnings growth in the future, thanks to its leading position in a massive (and growing) market.
ResMed estimates that worldwide, more than 900 million people suffer from sleep apnea and more than 380 million people live with chronic obstructive pulmonary disease (COPD). However, the vast majority have not yet been diagnosed due to the lack of awareness of both the medical community and the general public. However, ResMed’s addressable market grows each year as awareness gradually increases.
And while the estimated earnings for fiscal year 2023 are 30x, their shares are not cheap, I think the premium is justified because of their positive long-term growth prospects.
Motley Fool partner James Mickleboro does not own shares in ResMed Inc.
BHP Group Ltd.
What it does: BHP is one of the largest diversified miners in the world. While it is a major supplier of iron ore, it also produces metals such as copper and nickel that are essential for the global energy transition to renewables, including battery manufacturing.
By Brendon Lau: The great Australian has been hit by concerns about a global recession and declining demand for commodities. But there is too much bad news in the shares with broker Macquarie Group reiterating its recommendation to “outperform” the shares.
Higher diesel and energy costs have forced some miners to lower their production orientation, but the broker noted that these higher costs would accelerate the transition to green energy. BHP minerals, such as copper, are essential ingredients in this transition.
Macquarie also noted that BHP was trading with an attractive free cash flow performance for fiscal year 23 of 16% using its forecasts and 15% at spot prices. The broker’s 12-month price target on BHP’s share price is $ 51 per share.
…